Skip to content

MedVector

Telehealth that brings clinical trials to local doctors

Raised to date

$1M

of $1.1M offered across 1 Form D filing

Still open
$95K
Investors
1
Last filed
May 6, 2026

About

MedVector operates a telehealth platform that extends clinical trials beyond trial sites by turning a treating physician's office into an extension of the trial site. Its system lets a principal investigator at the trial site run trial sessions remotely with a patient's own physician, who monitors the patient's response under the investigator's instruction, so the physician never has to become a clinical trial investigator. The platform handles patient identification, referral matching, and compensating physicians for the added workload while preserving the patient-physician relationship. The company is based in El Segundo, California.

Rather than recruiting patients away from their doctors, MedVector keeps the treating physician in the loop and makes their office a remote extension of the trial site, so patients hear the trial recommendation from a doctor they already trust and physicians can refer without taking on investigator responsibilities.

Funding

  • Option to acquireFiled May 6, 2026Form D/A
    $1M/ $1.1M

Product

MedVector telehealth clinical trial platform

Clinical trial technology

A telehealth and healthcare-provider engagement platform that connects treating physicians to clinical trial sites, allowing a principal investigator to conduct trial sessions with a patient at their own physician's office and instruct that physician's staff on monitoring the patient's response.

  • Telehealth link between the trial site principal investigator and the treating physician's office
  • Patient identification and referral matching
  • Physicians refer without becoming clinical trial investigators

Built for

Pharmaceutical and biotech trial sponsors and clinical trial sites, reached through community physicians and their patients

People on file